Quest Diagnostics Inc Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)
Quest Diagnostics Inc (DGX) reported Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) of $19.00 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-22.
Discontinued › Notes
us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease · last filed 2021-02-22
- Quest Diagnostics Inc accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2020 was $19.00M.
| Period end | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 12 month |
|---|---|
| 2020-12-31 | $19.00M 10-K · filed 2021-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |